Table 2.
Relationship between FOXF2 expression in colon cancer and clinicopathological characteristics
| Item | Case (n) | FOXF2 expression | χ2 | P-value | |
|---|---|---|---|---|---|
|
| |||||
| Low | High | ||||
| Origin of specimens | |||||
| Colon cancer | 108 | 78 (72.22%) | 30 (27.78%) | ||
| Normal control tissues | 12 | 4 (33.33%) | 8 (66.67%) | 2.747 | 0.0060 |
| Gender | |||||
| Male | 75 | 50 | 25 | ||
| Female | 33 | 28 | 5 | 1.477 | 0.1397 |
| Age | |||||
| <50 years | 31 | 21 | 10 | ||
| ≥50 years | 77 | 57 | 20 | 0.6596 | 0.5095 |
| TNM stage | |||||
| Stage I/II | 74 | 48 | 26 | ||
| Stage III/IV | 34 | 30 | 4 | 2.518 | 0.0118 |
| Broders’ classification | |||||
| Grade I/II | 86 | 66 | 20 | ||
| Grade III/IV | 22 | 12 | 10 | 2.074 | 0.3137 |
| Distant metastasis | |||||
| Yes | 4 | 3 | 1 | ||
| No | 104 | 75 | 29 | 0.1264 | 0.8994 |
| Lymph node metastasis | |||||
| N0 | 73 | 47 | 26 | ||
| N1/N2 | 35 | 31 | 4 | 2.627 | 0.0086 |
Abbreviations: TNM = tumour-node-metastasis.